INVESTMENT AGREEMENTInvestment Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionThis Investment Agreement (this “Agreement”) is made and entered as of December 20, 2013 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (the “Company”), and Potomac Construction Limited (the “Investor”).
INVESTMENT AGREEMENTInvestment Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionThis Investment Agreement (this “Agreement”) is made and entered as of May 15, 2014 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (the “Company”), and Ernst Welmers (the “Investor”).
INVESTMENT AGREEMENTInvestment Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionThis Investment Agreement (this “Agreement”) is made and entered as of October 31, 2014 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (the “Company”), and Potomac Construction Limited (the “Investor”).
INVESTMENT AGREEMENTInvestment Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionThis Investment Agreement (this “Agreement”) is made and entered as of May 30, 2013 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (the “Company”), and Potomac Construction Limited (the “Investor”).
INVESTMENT AGREEMENTInvestment Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionThis Investment Agreement (this “Agreement”) is made and entered as of September 9, 2014 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (the “Company”), and Potomac Construction Limited (the “Investor”).
INVESTMENT AGREEMENTInvestment Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionThis Investment Agreement (this “Agreement”) is made and entered as of April 16, 2013 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (the “Company”), and Potomac Construction Limited (the “Investor”).
INVESTMENT AGREEMENTInvestment Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionThis Investment Agreement (this “Agreement”) is made and entered as of September 17, 2014 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (the “Company”), and Potomac Construction Limited (the “Investor”).
INVESTMENT AGREEMENTInvestment Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionThis Investment Agreement (this “Agreement”) is made and entered as of July 20, 2015 (the “Effective Date”) by and between Lightlake Therapeutics Inc., a Nevada corporation (the “Company”), and Potomac Construction Limited (the “Investor”).